Evidence map›Paper›PMID 42005168›Full record

ArticleCureus2026

Risk Factors for Severe Pyometra Uteri in Elderly Women: A Case-Control Study at a Tertiary Care Hospital in Japan.

Hiroshi Mori, Ayako Imai

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hiroshi MoriDepartment of Obstetrics and Gynecology, Kenwakai Otemachi Hospital, Kitakyusyu, JPN.
Ayako ImaiDepartment of Obstetrics and Gynecology, Kenwakai Otemachi Hospital, Kitakyusyu, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Pyometra uteri (PU) is an uncommon gynecologic condition characterized by purulent accumulation within the uterine cavity. Although it is typically managed conservatively with drainage and antibiotics, severe cases - particularly those complicated by uterine rupture (UR) - are associated with substantial morbidity and high mortality. Evidence regarding factors associated with severe PU remains limited, especially in aging populations. This study, therefore, explored clinical and microbiological factors potentially associated with severe PU in elderly women. Methods This retrospective case-control study included 120 patients diagnosed with PU at a tertiary-care hospital in Japan between January 2014 and September 2024. Severe cases were defined as those requiring intensive care unit (ICU) or high care unit (HCU) admission. Clinical characteristics, microbiological findings, and outcomes were compared between severe (n=10) and non-severe (n=110) cases. Because of the limited number of severe cases, multivariable logistic regression was not feasible; therefore, univariate logistic regression analyses were performed, with additional age- and BMI-adjusted stratified analyses using the Mantel-Haenszel method. Receiver operating characteristic (ROC) curve analysis was used to explore the predictive performance of abscess size. Results The median age of the study population was 84 years. Ten patients (8.3%) were classified as severe; and all had UR. The in-hospital mortality rate among severe cases was 50%. Several clinical and microbiological variables were statistically associated with severe disease in univariate analyses, including fever, abdominal pain, presence of coexisting adenomyosis, detection of extended-spectrum β-lactamase (ESBL)-producing

Indexed as

acute care medicineelderly womenfemale urology and uro oncologygeriatric sepsisjapanese geriatricspyometra uteriuterine rupture

Identifiers

PMID42005168
PMCPMC13085485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.